The therapeutic effects of combining transcranial direct current stimulation with intermittent oroesophageal tube feeding in treating dysphagia among ischemic stroke survivors: A double-blind randomized and controlled study
10.3760/cma.j.cn421666-20240906-00720
- VernacularTitle:经颅直流电刺激联合经口至食管间歇管饲治疗脑梗死后吞咽障碍的疗效观察
- Author:
Zengjin LIU
1
;
Rongzhi CAO
;
Heping LI
;
Liugen WANG
;
Xi ZENG
;
Xiaoyun LI
Author Information
1. 郑州大学第一附属医院神经外科，郑州 450000
- Publication Type:Journal Article
- Keywords:
Stroke;
Dysphagia;
Transcranial direct current stimulation;
Tube feeding
- From:
Chinese Journal of Physical Medicine and Rehabilitation
2025;47(9):822-826
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To observe any therapeutic effect of transcranial direct current stimulation (tDCS) combined with intermittent oroesophageal tube feeding (IOE) on dysphagia among ischemic stroke survivors.Methods:Eighty-four ischemic stroke survivors with dysphagia were randomized into an observation group and a control group, each of 42. In addition to conventional rehabilitation, swallowing training and IOE, the observation group received tDCS while the control group received sham stimulation. Before and after 14 days of this treatment, both groups′ swallowing, life quality and depression were evaluated using the Penetration Aspiration Scale (PAS), the Functional Oral Intake Scale (FOIS), the Dysphagia Handicap Index (DHI), and a 9-item patient health questionnaire (PHQ-9).Results:There were no significant differences between the two groups before the experiment in terms of their general data, their average PAS, FOIS, DHI or PHQ-9 scores, or the incidence of depression. After the treatment, significant improvement was observed in the above indicators among both groups, but with significantly better average PAS, FOIS, DHI [(51.25±6.78) vs. (44.78±5.75)] and PHQ-9 [(4.17±1.15) vs. (6.01±1.93)] scores and less depression (14.29% vs. 42.86%) in the observation group compared with the control group.Conclusions:Combining tDCS with IOE better improves swallowing function, depression, and life quality after an ischemic stroke.
